Copy
Dear all,

The World Health Organization (WHO) Global TB Programme, in close collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria, the United States Agency for International Development and the Global Drug Facility of the Stop TB Partnership have updated the Frequently Asked Questions (FAQs) document on WHO’s Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis.

These FAQs reinforce the key messages highlighted in the Rapid Communication released in December 2019 and inform national TB programmes and other stakeholders about the main steps needed to support rapid transition and planning at the country level.
 
We would like to thank colleagues for their comments and contribution to the FAQs.
 
The updated FAQs are available here
World Health Organization, 
Global TB Programme
20, Avenue Appia, CH-1211, Geneva, Switzerland               
Tel: (+41) 22 791 4695. 
Email: gtbprogramme@who.int 

For more information please go to 
www.who.int/tb






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
World Health Organization · 20 Avenue Appia · Geneve CH-1211 · Switzerland